Answer
Mylotarg (gemtuzumab ozogamicin) must be reconstituted and diluted, then administered by intravenous infusion over two hours under close clinical monitoring, including pulse, blood pressure and temperature, never as an intravenous push or bolus.
Sources for this answer
- MYLOTARG 5mg powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.2 Posology and method of administration · Version 13Document updated
Sources checked